UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review
Merck: European Commission Approves KEYTRUDA Plus Chemotherapy In Breast Cancer
Roivant Sciences: FDA Approves Dermavant's VTAMA Cream, 1% For Plaque Psoriasis In Adults
SpringWorks Therapeutics Says Nirogacestat Meets Endpoints In Phase 3 DeFi Trial